AzTrials
AzTrials

AggressionNCT04204759

Transcranial Direct Current Stimulation and Antisocial Behavior

A study testing Transcranial direct current stimulation in people with Aggression, run by Nanyang Technological University at 1 site in Singapore.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The main objective of this study is to investigate the causal relationship between prefrontal cortex activity and antisocial behavior, as well as risk factors for antisocial behavior. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Aggression
What is being tested?
Transcranial direct current stimulation
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
101 participants
Where
1 siteSingapore
Study dates
3 Nov 2019to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Above 18 (with parental consent) or above 21 (without parental consent)
  • Able to understand the nature of the study and give informed consent

Who cannot join

  • History of or active neurologic, cardiovascular, or psychiatric disease including anxiety disorders (e.g., PTSD, panic attacks, obsessive-compulsive disorder) and mood disorders (e.g., depression)
  • Currently consuming anti-convulsant, anti-psychotic, or sedative/hypnotic medications
  • Currently consuming anti-depressants
  • History of seizures
  • Metallic implants on scalp
  • Participated in any other non-invasive brain stimulation study in the same day
  • Ever had an adverse reaction to tDCS

Trial locations and contacts

1 site in 1 country.

Singapore1 site
  • Nanyang Technological University

    Singapore, 639818

Other trials in Singapore

About this study

Official title: The Effect of Transcranial Direct Current Stimulation of the Prefrontal Cortex on Antisocial Behavior

The main objective of this study is to investigate the causal relationship between prefrontal cortex activity and antisocial behavior, as well as risk factors for antisocial behavior. Specifically, this study tests the hypothesis that upregulating activity in the prefrontal cortex through a non-invasive form of brain stimulation, transcranial direct current stimulation (tDCS) will reduce antisocial and aggressive behavior. The effects of 3 days of anodal stimulation over the prefrontal cortex are assessed.

Conditions
Aggression
Being tested
Transcranial direct current stimulation, Sham transcranial direct current stimulation
Keywords
transcranial direct curren stimulation, antisocial behavior
Medical subject headings
Aggression, Antisocial Personality Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcranial direct current stimulationDevice

    Non-invasive stimulation will be conducted using a tDCS device (StarStim, Neuroelectrics, Spain).

  • Sham transcranial direct current stimulationDevice

    The same device will be used as in the active stimulation group, but stimulation will be terminated after 30 seconds.

Study groups in NCT04204759
Study groupRoleWhat they receive
Anodal stimulationExperimentalParticipants in the active stimulation group will undergo anodal transcranial direct current stimulation (tDCS). tDCS will be delivered by a battery-driven, constant-current stimulator connected to two saline-soaked surface sponge electrodes. An anodal electrode (25cm2) will be placed over the ventromedial prefrontal cortex and one cathodal electrode (35cm2) will be placed over the occipital cortex. Scalp electrodes will be positioned according to the 10-20 EEG international system. A current of 2mA will be applied for 20 minutes and the current will be ramped up and down over 30 seconds at the beginning and end of the stimulation period.
Receives: Device: Transcranial direct current stimulation
Sham stimulationSham comparatorThe sham tDCS condition will involve the same placement of the electrodes, current intensity, and ramp-up/down time as the active tDCS condition, but stimulation will only last for 30 seconds.
Receives: Device: Sham transcranial direct current stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Points in the Point Subtraction Aggression Paradigm after stimulation

    The number of points earned on the lab task will be assessed.

    Measured: Within 1 hour after the third consecutive active tDCS or sham session

  2. Antisocial behavior inclinations after stimulation

    This will be assessed using 5 hypothetical scenarios in which someone commits a criminal or antisocial act. Participants will respond to the likelihood that they would commit the act in the scenario according to a 10-point Likert scale. Responses are measured on a scale ranging from zero (no chance at all) to 10 (100% chance). A higher value reflects a greater intention to engage in the antisocial act.

    Measured: Within 1 hour after the third consecutive active tDCS or sham session

  3. Moral judgment ratings after stimulation

    This will be assessed using 5 hypothetical scenarios in which someone commits a criminal or antisocial act. Participants will rate the moral wrongfulness of the act in the scenario on a scale from 0 (not at all) to 10 (very). A higher score reflects a greater perception of moral wrongfulness regarding the antisocial act.

    Measured: Within 1 hour after the third consecutive active tDCS or sham session

  4. Delay discounting rates after stimulation

    Participants' responses to 5 questions indicating if they would prefer a smaller reward today or a larger reward in the specified number of days will be assessed. The delay discount rates (k) of monetary rewards will be calculated based on the responses to the 5 trials.

    Measured: Within 1 hour after the third consecutive active tDCS or sham session

  5. Helping behavior after stimulation

    This will be assessed based on the number of easy and hard puzzles participants choose to assign to another participant in the study.

    Measured: Within 1 hour after the third consecutive active tDCS or sham session

  6. Antisocial behavior after stimulation

    This will be assessed based on the participants' accurate reporting of the number of problems correctly solved in a task.

    Measured: Within 1 hour after the third consecutive active tDCS or sham session

Secondary outcomes (1)
  1. Number of participants with adverse events

    The number of participants reporting the experience of sensations resulting from tDCS will be recorded.

    Measured: Within 1 hour after each of the 20-minute active tDCS or sham sessions

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2019
  2. Study start3 Nov 2019
  3. Primary completion1 May 2022
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
101 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04204759
Sponsor's protocol ID
IRB-2019-06-072
Status last verified
Oct 2022
First submitted
17 Dec 2019
Last updated
18 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Transcranial direct current stimulation in people with Aggression, run by Nanyang Technological University at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Points in the Point Subtraction Aggression Paradigm after stimulation (time frame: Within 1 hour after the third consecutive active tDCS or sham session). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Oct 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in